Der Einfluss von Lebererkrankungen auf die ambulant erworbene Pneumonie

• Literatur

• 1 Jalan R. et al. Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013. J Hepatol 2014; 60: 1310-1324
• 2 Bellinghausen C. et al. Chronic liver disease negatively affects outcome in hospitalised patients with community-acquired pneumonia. Gut 2021; 70: 221-222
• 3 Fernández J. et al. Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis. Gut 2018; 67: 1870-1880
• 4 Xu L. et al. Pneumonia in patients with cirrhosis: Risk factors associated with mortality and predictive value of prognostic models. Respir Res 2018; 19: 1-11
• 5 Bajpai V. et al. Spectrum of respiratory viral infections in liver disease patients with cirrhosis admitted in critical care unit. J Lab Physicians 2019; 11: 356-360
• 6 Rishi P. et al. Inhibition of Endotoxin-Induced Hepatotoxicity by Melatonin in Rats. Int J Biomed Sci 2008; 4: 103-112
• 7 Jaeschke H. et al. Mechanisms of Hepatotoxicity. Toxicological Sciences 2002; 65: 166-176
• 8 Björnsson ES. Drug-induced liver injury due to antibiotics. Scand J Gastroenterol 2017; 52: 617-623
• 9 Adikwu E, Brambaifa N. Ciprofloxacin Cardiotoxicity and Hepatotoxicity in Humans and Animals. Pharmacology & Pharmacy 2012;
• 10 Ruan X. et al. Liver injury after antiviral treatment of critically ill patients with COVID-19: a single-centered retrospective cohort study. Ann Palliat Med 2021; 10: 2429-2438
• 11 Zhai G. et al. Drug-Induced Liver Disturbance During the Treatment of COVID-19. Front Pharmacol 2021;
• 12 Gao F. et al. Model for end-stage liver disease and pneumonia: An improved scoring model for critically ill cirrhotic patients with pneumonia. Turk J Gastroenerol 2019; 30: 532-540
• 13 Pletz MW. et al. Unmet needs in pneumonia research – a comprehensive approach by the CAPNETZ Study Group. Respir Res 2022;